Image

Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers

Study on Tumor Cell and DNA Detection in Patients with Solid Cancers

Recruiting
18 years and older
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates the detection of tumor cells and DNA in patients with solid cancers. It focuses on understanding how cancer spreads by examining circulating tumor cells and DNA in the blood, urine, and bone marrow.

The study evaluates these biological markers to enhance knowledge about cancer biology and to potentially develop personalized therapies for cancer treatment.

  • Who can participate: Adults over 18 with solid cancer diagnoses, including lung, esophageal, and stomach cancers, are eligible. Participants must be able to give informed consent. Eligibility for a control group will be determined based on specific criteria related to health status and absence of cancer.
  • Study details: Participants will provide blood, urine, and bone marrow samples for analysis. The study will examine these samples for tumor cells and DNA. A placebo is not involved.
Print
Study details
    Non-small Cell Lung Cancer
    Esophageal Cancer
    Gastric Cancer
    Pancreatic Cancer
    Hepatocellular Cancer
    Colorectal Cancer

NCT02838836

University of Missouri-Columbia

30 July 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.